Home › Treatment-Resistant Depressive Disorder › New York
Treatment-Resistant Depressive Disorder clinical trials in New York
11 studies for Treatment-Resistant Depressive Disorder are looking for participants at sites in New York.
Cities in New York
A Study of Esketamine Nasal Spray Versus Placebo Spray in Adult Participants With Treatment-resistant Depression
- Neurobehavioral Research Inc, Cedarhurst
- The Medical Research Network, LLC, New York
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07716098Biomarker-Guided Antidepressant Selection
- Weill Cornell Medicine, New York
RecruitingPhase 4
Ages 18 to 70 · All sexes · Updated Sep 23, 2026 · NCT07680140DBS for TRD With the Medtronic Percept PC
- Icahn School of Medicine at Mount Sinai, Mount Sinai West, New York
Recruiting
Ages 25 to 70 · All sexes · Updated Sep 22, 2026 · NCT05773755DBS for Depression
- Zucker Hillside Hospital, Queens
RecruitingPhase 1
Ages 18 to 65 · All sexes · Updated Sep 14, 2026 · NCT06096207ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response
- Integrative Clinical Trials LLC, Brooklyn
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Sep 14, 2026 · NCT07284667Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
- Mount Sinai Hospital, New York
Recruiting
Ages 22 to 70 · All sexes · Updated Aug 28, 2026 · NCT06423430A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
- Dent Neurological Institute, Amherst
- Trinity Medical, Lewiston
- Icahn School of Medicine at Mount Sinai, New York
- and 1 more
Recruiting
Ages 18 and older · All sexes · Updated Jun 15, 2026 · NCT03887715A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
- The Medical Research Network, LLC, New York
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated May 11, 2026 · NCT06524830Maintenance rTMS for Depression (Maitr-De)
- Weill Cornell Medicine, New York
Recruiting
Ages 18 to 80 · All sexes · Updated Apr 29, 2026 · NCT06938841ALTO-207 in Adults With Treatment-resistant Depression (TRD)
- Site 7170, Amherst
- Site 7055, Cedarhurst
- Site 7162, Lewiston
- and 1 more
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Apr 28, 2026 · NCT07553637Biomarker-guided rTMS for Treatment Resistant Depression
- Weill Cornell Medicine, New York
RecruitingPhase 3
Ages 22 to 65 · All sexes · Updated Feb 25, 2026 · NCT04041479From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.